The Effects of Spironolactone on Inflammation in a Rodent Model of Pulmonary Arterial Hypertension
The Effects of Spironolactone on Inflammation in a Rodent Model of Pulmonary Arterial Hypertension
批准号:
9549491
负责人:
Jason Matthew Elinoff
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Animal ModelCardiacCardiac Catheterization ProceduresCardiovascular DiseasesCell Culture TechniquesCessation of lifeDiagnosisDiseaseEchocardiographyExposure toGoalsHeartHeart failureHypoxiaImageInflammationLeftMagnetic Resonance ImagingMineralocorticoid ReceptorModelingPatient-Focused OutcomesPatientsPharmaceutical PreparationsProgressive DiseaseProtocols documentationPulmonary HypertensionPulmonary artery structureRattusReproducibilityResolutionRight Ventricular FunctionRodentRodent ModelSU 5416SideSpironolactoneStressStructureSubcutaneous InjectionsTechnical ExpertiseVEGFA geneWorkeplerenoneexperimental studyheart functionimprovedinhibitor/antagonistpressurepulmonary arterial hypertensionpulmonary artery endothelial cellreceptor
中文摘要
本研究的第一部分已经完成。在过去的一年里,我们继续在啮齿动物心脏导管插入术和心脏磁共振成像方面发展必要的技术技能。为了提高右心室功能评估的分辨率和准确性,我们将心脏磁共振成像作为方案的一部分,而不是超声心动图。研究的第二部分,确定螺内酯与依普利酮的影响,于2017年5月开始,我们已经完成了第一组实验。
英文摘要
Part 1 of this study has been completed. Over the past year, we have continued to develop the necessary technical skills in rodent cardiac catheterization and cardiac magnetic resonance imaging. We have implemented cardiac resonance imaging as part of the protocol instead of echocardiography in order to improve both the resolution and precision of our assessments of right ventricular function. Part 2 of the study, determining the effects of spironolactone versus eplerenone, began in May 2017 and we have completed the first set of experiments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Phase 1 Clinical Trial of ABI-009, an mTOR Inhibitor, for Patients with Severe Pulmonary Arterial Hypertension (PAH)
-
批准号:10683664
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jason Matthew Elinoff
-
依托单位:
A Phase 1 Clinical Trial of ABI-009, an mTOR Inhibitor, for Patients with Severe Pulmonary Arterial Hypertension (PAH)
-
批准号:10262632
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jason Matthew Elinoff
-
依托单位:
The Effects of Spironolactone on Inflammation in a Rodent Model of Pulmonary Arterial Hypertension
-
批准号:10683663
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jason Matthew Elinoff
-
依托单位:
The Effects of Spironolactone on Inflammation in a Rodent Model of Pulmonary Arterial Hypertension
-
批准号:10262630
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jason Matthew Elinoff
-
依托单位:
Cellular Models of PAH-Associated Molecular Defects as a Tool for Identifying New Therapeutic Targets
-
批准号:10262650
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jason Matthew Elinoff
-
依托单位:
The Effects of Spironolactone on Inflammation in a Rodent Model of Pulmonary Arterial Hypertension
-
批准号:9352015
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jason Matthew Elinoff
-
依托单位:
Cellular and Molecular Consequences of SARS-VoV2 Infection in Pulmonary Vscular Endothelium
-
批准号:10262653
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jason Matthew Elinoff
-
依托单位:
Cellular Models of PAH-Associated Molecular Defects as a Tool for Identifying New Therapeutic Targets
-
批准号:10683667
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jason Matthew Elinoff
-
依托单位:
海外基金